Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018.
Buziashvili M, Davtyan H, Sereda Y, Denisiuk O, Gozalov O, Lomtadze N, Hovhannesyan A. Buziashvili M, et al. Among authors: lomtadze n. Monaldi Arch Chest Dis. 2021 Jan 14;91(1):10.4081/monaldi.2021.1649. doi: 10.4081/monaldi.2021.1649. Monaldi Arch Chest Dis. 2021. PMID: 33470083 Free PMC article.
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Gomez GB, Siapka M, Conradie F, Ndjeka N, Garfin AMC, Lomtadze N, Avaliani Z, Kiria N, Malhotra S, Cook-Scalise S, Juneja S, Everitt D, Spigelman M, Vassall A. Gomez GB, et al. Among authors: lomtadze n. BMJ Open. 2021 Dec 3;11(12):e051521. doi: 10.1136/bmjopen-2021-051521. BMJ Open. 2021. PMID: 34862287 Free PMC article.
Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
Adamashvili N, Baliashvili D, Kuchukhidze G, Salindri AD, Kempker RR, Blumberg HM, Lomtadze N, Avaliani Z, Magee MJ. Adamashvili N, et al. Among authors: lomtadze n. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):326-333. doi: 10.5588/ijtld.21.0450. Int J Tuberc Lung Dis. 2022. PMID: 35351237 Free PMC article.
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.
Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, Skrahina A, Dravniece G, Kuksa L, Rich M, Khachatryan N, Germanovych M, Kadyrov A, Terleieva I, Akhundova I, Adenov M, Durdyeva M, Kiria N, Parpieva N, Yatskevich N, Jumayev R, Nurov R, Diktanas S, Vilc V, Migliori GB, Yedilbayev A. Korotych O, et al. Among authors: lomtadze n. Lancet Infect Dis. 2024 Oct;24(10):1151-1161. doi: 10.1016/S1473-3099(24)00228-7. Epub 2024 Jun 13. Lancet Infect Dis. 2024. PMID: 38880112 Free PMC article.
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region.
Migliori GB, Korotych O, Achar J, Ciobanu A, Dravniece G, Germanovych M, Gurbanova E, Hovhannesyan A, Khachatryan N, Kuksa L, Lomtadze N, Rich ML, Skrahina A, Yedilbayev A. Migliori GB, et al. Among authors: lomtadze n. IJTLD Open. 2024 Mar 1;1(3):103-110. doi: 10.5588/ijtldopen.24.0035. eCollection 2024 Mar. IJTLD Open. 2024. PMID: 38966407 Free PMC article.
High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, Lomtadze N, Vashakidze L, Hao L, Del Rio C, Tangpricha V, Blumberg HM, Ziegler TR. Tukvadze N, et al. Among authors: lomtadze n. Am J Clin Nutr. 2015 Nov;102(5):1059-69. doi: 10.3945/ajcn.115.113886. Epub 2015 Sep 23. Am J Clin Nutr. 2015. PMID: 26399865 Free PMC article. Clinical Trial.
22 results